Stockreport

Cardiff Oncology, Inc. (NASDAQ:CRDF) Q4 2023 Earnings Call Transcript [Yahoo! Finance]

Cardiff Oncology, Inc.  (CRDF) 
PDF Reported EPS is $-0.21, expectations were $-0.26. CRDF isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter ( see the details here [Read more]